Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_298ec895e44c0b827f85f0e8a8582667 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ddbf5977e238579e73a412dfd587881 |
publicationDate |
2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114401993-A |
titleOfInvention |
Methods of using IL-17RA antibodies to treat nonalcoholic fatty liver disease (NAFLD) |
abstract |
The present disclosure relates to the use of an IL-17 antagonist (eg, a monoclonal antibody that specifically binds to IL-17 receptor A (IL-17RA)) for the treatment of non-alcoholic fatty liver disease (NAFLD) and subsets thereof (eg, non-alcoholic fatty liver disease) method of steatohepatitis (NASH). |
priorityDate |
2019-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |